AbbVie
Developed promotional materials for key opinion leaders (KOLs), creating scientifically grounded content aligned with available evidence, ensuring claim traceability and compliance with pharmaceutical promotion codes of practice.
Medical Writing Clients & Success Stories
For years I have supported biopharmaceutical, biotechnology, and scientific-society partners on their medical writing, regulatory, and medical affairs projects.
Acellera
Managed grant programs and corporate support, coordinating the administrative and scientific processes for calls, evaluation, follow-up of grants, and related corporate documentation.
Adelphi
Scientific writing for publication, structuring manuscripts according to editorial standards and applicable reporting guidelines (e.g., ICMJE, CONSORT, PRISMA depending on design), from initial draft to submission-ready version.
Aixial
Medical writing and preparation of regulatory documentation aligned with European Medicines Agency (EMA) requirements, combining scientific methodological rigor with the compliance and formatting demands of regulatory documents.
Ascelia Pharma
Scientific writing for Ascelia, supporting the production of research outputs with the scientific rigor required.
AstraZeneca
Created promotional materials for KOLs, translating clinical evidence into precise scientific communication assets grounded in primary sources and tailored to the target healthcare professional.
Biomed Valley Discoveries
Supported updates to scientific content, particularly investigator's brochures — key regulatory documentation reference documents in clinical development.
Cactus Life Sciences
Reviewed promotional materials aimed at KOLs, verifying scientific accuracy, alignment between claims and supporting references, and consistency with published evidence.
CSL Vifor
Scientific support for clinical-trial presentations and congress content, plus strategic medical affairs consulting, helping communicate data rigorously and plan scientific dissemination.
Dentaid
Managed and moderated advisory boards, drafted medical consensus documents, and provided strategic medical affairs support, facilitating expert deliberation and integrating conclusions into medical strategy.
Ferrer
KOL management and strategic medical affairs project development, coordinating relationships with opinion leaders and supporting evidence generation and communication initiatives.
Fundació Lluita
Scientific writing, supporting the publication of research results with the methodological rigor and clarity expected in peer-reviewed literature.
Gilead
KOL management and strategic medical affairs projects, aligning scientific communication and expert engagement activities with the organization's medical objectives.
GSK
Created KOL promotional materials and congress content, ensuring communication assets and scientific presentations accurately reflected evidence and met quality and compliance requirements.
Medhionine
Wrote, reviewed, and supervised scientific articles, providing end-to-end manuscript quality control from methodological coherence to data interpretation accuracy and editorial suitability.
Menarini
Scientific writing, strategic medical affairs consulting, and development of global medical department standard operating procedures (SOPs), contributing to scientific output and corporate process standardization.
OM Pharma
Scientific writing, transforming research results into publishable manuscripts aligned with international scientific communication standards.
Organon
Generated evidence-based scientific content for KOLs, developing materials oriented toward communication with opinion leaders.
Otsuka
Strategic scientific support for evidence generation and promotional materials development, integrating evidence planning with downstream communication under documented substantiation criteria.
Regeneron
Reviewed scientific documentation for advisory boards, verifying the robustness and accuracy of material intended for expert deliberation.
Reig Jofre
Strategic medical training for medical plan development, providing educational content and scientific guidance to shape medical strategy.
RENACER
CRO function for the registry, managing participating sites, resolving incidents, generating content, and providing scientific support to ensure registry operations, data quality, and associated communication.
Sanofi
Innovative management of an IT platform, KOL scientific content generation, and congress content development, combining technological process coordination with rigorous scientific communication.
SEOM
Scientific writing for the Spanish Society of Medical Oncology (SEOM), supporting scientific production with the rigor expected in scientific society settings.
Shionogi
KOL management and strategic medical affairs projects, coordinating expert relationships and the development of strategic medical initiatives.
Springer
Scientific support on strategic and operational projects together with scientific writing, contributing to the execution of editorial and scientific initiatives and manuscript production.
Tecnimede
Scientific writing and KOL content management, combining scientific literature production with the development and coordination of materials for opinion leaders.